Navigation Links
Competing San Francisco Bay Area Hospitals Demonstrate That Collaborative Efforts Contribute to Reduced Hospital Errors and Saved Lives
Date:4/21/2008

t and prevention of harm to the more than 450,000 patients admitted each year to its participating hospitals. Originally known as the Bay Area Patient Safety Collaborative, the effort was renamed Beacon Collaborative when GBMF provided nearly two million dollars in April 2007 for the second phase of the collaborative's work. The effort was initiated through the Hospital Council in 2005 as a communications hub for hospitals participating in the Institute for Healthcare Improvement's "100,000 Lives Campaign."

GBMF funding goes toward Beacon support of individual hospital commitments to achieving significant measurable improvement for the initiatives selected. Hospitals are based in Santa Clara, San Mateo, San Francisco, Marin, and Alameda counties.

Beacon has sponsored a variety of Webinars, workshops, and day-long conferences during the past 12 months, attended by well over 1,000 persons. The Beacon Institute offers intensive courses in the science of quality improvement to hospital quality leaders. A four-day program focuses on development of practical improvement projects that are tested in the participants' hospitals. Beacon staff includes two improvement advisors, Barbara Debaun, RN, MSN, CIC, and Pat Teske, RN, MHA, who teach the courses and consult with Beacon hospitals on their improvement initiatives.

"Beacon supports the already outstanding and multi-faceted efforts of Bay Area hospitals to reduce errors and assure patient safety," said Dr. Spurlock. "The GBMF grant enables us to provide educational programs, unique peer-to- peer learning networks, and most significantly -- a regional forum in which hospitals in the same community with shared values can collect patient safety data confidentially and compare their own performance against that of peers on several important patient safety initiatives."

Much of the impetus for patient safety across the nation and in the Bay Area was sparked by the 1999 landmark Institutes of Medicine
'/>"/>

SOURCE Beacon Collaborative
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HCV and HBV spreading more slowly among injection drug users in San Francisco
2. San Francisco Psoriasis Event Tonight Will Celebrate First National Short Sleeve Day
3. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
4. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
5. The era of global aging: GSA showcases cutting-edge San Francisco meeting topics
6. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
7. Press briefings to address longevity, mobility, brain fitness at GSAs San Francisco meeting
8. Hooray for the Bay! San Francisco Officially Named Best Place to Leave Your Heart...and Keep Your Health
9. Run-in-a-Million Run from San Francisco to Los Angeles to Raise Awareness About AIDS and HIV Testing
10. BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards
11. Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Dr. Stephen Cohen Hired As New CEO, ATLANTA,...r Group,(GMCG) announced today that MELCO Investme...ment fund, has signed on as a key partner with a,s...the investment, GMCG has,also appointed Dr. Stephe...,surgeons, as its new CEO., (Photo: http://www.n...
(Date:7/23/2008)...d and Medicare Rules Highlighted; a Focus on Preve...tions, LANSING, Mich., July 23 /PRNewswire/ -- Th...&PSI), a national leader in clinical risk manageme... care institutions and,providers, today announced ... conference., The conference will take place Sept...
(Date:7/23/2008)... Michigan Takes Top Honors as the #1 Healthiest Ci...PRNewswire-USNewswire/ -- AARP The Magazine, the,d...largest-circulation,magazine with more than 34 mil...st cities to live and retire in with Ann Arbor, MI...go, ND taking the top five rankings.,Featured in t...
(Date:7/23/2008)...a., July 23 /PRNewswire-USNewswire/ -- The HealthC...m ) today announced that Dr. Fran Cogen,MD, direc...am at Children,s,National Medical Center, will pro...om, a site offering connections to a community of ...priate consultation by a dietician, social,worker,...
Breaking Medicine News(10 mins):Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 2Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 3Health News:The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5Health News:Children's National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Network's Teen Diabetes Site 2
...nza can be slowed by immunizing chickens. The dise...vaccine has been developed for protecting chickens...ndrea Gambotto of the University of Pittsburgh. ... advantageous way of stopping the spread of the di...
...ter of the Indian state of Kerala underwent a surg...ng his hip after a fall. // He was visiting Switze..., with the object of promoting his state as an inv...overing well after the surgery, even though he wil...
...ission (NHRC) has called for a report with regard ...dneys and has issued the Chief Secretary and the D...unjab with a notice. // As many as 300 laborers i...eys since the year 2001, and about 25 of them are ...
...e US in 2005 from the fatal arrhythmias through de...As many as 1,70,000 people in North America receiv...o found this to be uncomfortable, unnecessary, and...loped recently to find out which of the patients a...
Other Medicine News:
(Date:7/22/2008)...r Therapeutics Development Initiative bring MJFF,s...t deadline January 20,2009, NEW YORK, July 22 /P...,speed delivery of transformative treatments and a...Foundation for Parkinson,s Research has awarded,$2...ch teams. The awards,were granted under MJFF,s The...
(Date:7/22/2008)...T Study Confirms Tyrima Exhibits Excellent Drug-Li... - Results Support Initiation of Phase II Clinical.../- CeNeRx BioPharma,Inc., a clinical...vative,treatments for diseases of the central nerv...ead candidate Tyrima(TM) into Phase II trials for ...
(Date:7/22/2008)...O, Calif., July 22 /- Hyperion,Therap... patient enrollment,in its Phase 1/2 clinical tria... scavenging effects of HPN-100 (formally called GT...patients with urea cycle disorders,(UCD). The comp...th quarter,of this year., (Logo: http://www.news...
(Date:7/22/2008)...novative Laser Lipolysis Technology in the Europea..., Mass., July 22 /- Cynosur...manufacturer of a broad array of,light-based aesth...CE Mark,for Smartlipo MPX(TM), the company,s high-...liquefy fat and tighten skin through collagen,remo...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Living longer with obesity means heavier burden for hospitals 7969 1Living longer with obesity means heavier burden for hospitals 7969 2Living longer with obesity means heavier burden for hospitals 7969 3Mutated Suppressor Gene Leads to a Type of Breast Cancer 7967 1Mutated Suppressor Gene Leads to a Type of Breast Cancer 7967 2Mutated Suppressor Gene Leads to a Type of Breast Cancer 7967 3New drug candidate knocks out resistant form of chronic myeloid leukemia 7964 1New drug candidate knocks out resistant form of chronic myeloid leukemia 7964 2Decreasing access to cigarettes for youth in the Minnesota Adolescent Community Cohort Study 7961 1
...lif.--(BUSINESS WIRE)--May 15, 2007 - Synthetic Bl...ed positive data from,a statistical analysis of it...h traumatic brain injury. In line with preliminary...ical results,confirmed that the primary endpoint o...red with baseline was met. Data also show a,decrea...
...th ISIS 301012 produced at least 45% additional,re...,maximally-tolerated lipid-lowering therapies, CAR... -- Isis,Pharmaceuticals, Inc. announced updated r...ISIS 301012 in patients with homozygous,familial h...ch were,presented in March at the of Cardiology An...
Other Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek® now makes them available to you! Only holders of the coveted Meisterbrief certificate, wh
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek now makes them available to you! Only holders of the coveted Meisterbrief certificate, which r
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek now makes them available to you! Only holders of the coveted Meisterbrief certificate, which r
Medicine Products: